Authors' Reports

Fanghong Lu
describes for SIIC the most significant aspects of his article
describe para SIIC los aspectos relevantes de su artículo

A long-term efficacy and safety study
DIURETICS OR ARB ADDED TO CCB IN TREATMENT OF HYPERTENSION

Long-term combination therapy with amlodipine plus amiloride/hydrochlorothiazide or amlodipine plus telmisartan was effective and safe for the high-risk hypertensive patients in China.

The article was published by
El artículo fue publicado por
International Journal of Clinical Practice
Volume / Volumen: 66
Number / Número: 8
First and last pages / Páginas inicial-final: 792-799
Year / Año: 2012
Month / Mes: august


This journal, which is covered by SIIC Data Bases,
is part of the bibliographic collections of the Biblioteca Biomédica (BB) SIIC.
Esta revista, clasificada por SIIC Data Bases,
integra el acervo bibliográfico de la Biblioteca Biomédica (BB) SIIC.
icopagok.gif



Principal institution where the research took place
Institución principal de la investigación
山东省医学科学院基础医学研究所, 济南市, 山东省, China


a-livro3.gif
Authors' Report

Crónica del Autor
Print

Bibliographic references
Referencias bibliográficas

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-97, 2002.
Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-72, 2003.
Dahlöf B, Sever PS, Poulter NR, et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366:895-906, 2005.
Mancia G, De Backer G, Dominiczak A, et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25:1751-62, 2007.
Wang W, Ma L, Zhang Y, et al. The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics. J Hum Hypertens 25:271-7, 2011.
Wu Y, Huxley R, Li L, et al. China NNHS Steering Committee; China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 118:2679-86, 2008.
Yang J, Lu F, Zhang C, et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 33:331-7, 2010.

Other articles written by the author Fanghong Lu
Otros artículos de Fanghong Lu

1. Yang J, Lu F, Zhang C et al. Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertens Res 2010; 33:331-7.
2. 44. Zhao Y, Lu F, Sun H, Liu Z, Zhao Y, Sun S, Wang S, Diao Y, Zhang H. Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in Shandong Province of China. J Clin Hypertens (Greenwich). 2012 Sep;14(9):637-643.




SIIC System of Assisted Editing (SSEA)
/ Sistema SIIC de Edición Asistida (SSEA)

Fanghong Lu was invited by SIIC on
Fanghong Lu fue invitado por SIIC el
2012, october 18
  The authors' report was accepted on
La crónica del autor fue aprobada el
2021, march 9
The authors' report was accepted on
La crónica del autor fue aprobada el
2021, march 9
Published in siicsalud
Publicado en siicsalud
2021, june 7





The article is strictly related to the following sections of siicsalud
El artículo se relaciona estrictamente con las siguientes secciones de siicsalud

 
Cardiology
/ Cardiología
 
Pharmaceutical Medicine
/ Medicina Farmacéutica
 

and secondarily related to the following sections

y secundariamente con las siguientes secciones

Primary Care
Atención Primaria

Clinical Cardiology
Cardiología Clínica

Hypertension
Hipertensión Arterial

Pharmacology
Farmacología

Geriatrics
Geriatría

Family Medicine
Medicina Familiar

Internal Medicine
Medicina Interna

Information about the full text
Acerca del trabajo completo


A 48-Week Study of Amlodipine Plus Amiloride/Hydrochlorothiazide Vs. Amlodipine Plus Telmisartan in the Treatment of Hypertension.


Author / Autor
Fanghong Lu1

1 Professor, 山东省医学科学院基础医学研究所, Jinan, China, Director


Access to the original source
International Journal of Clinical Practice

Article URL:
/ URL del artículo:
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-1241

URL of Abstract:
/ URL del abstract:

URL of Abstract page in Medline:
/ URL del abstract en Medline:
http://www.ncbi.nlm.nih.gov/pubmed/22805271

URL of Abstract page in Scielo:
/ URL del abstract en Scielo:

URL of Abstract page in Scopus:
/ URL del abstract en Scopus:

URL of Abstract page in Embase:
/ URL del abstract en Embase:

Other data bases:
/ Otras bases de datos:

siic DB:
/ siic DB:
http://www.siicsalud.com/main/distriprinrel.php
ua32218